United States · FDA National Drug Code directory

Duloxetine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-8608_bfb65611-4b5e-4959-84a8-fd90fc2bafdc
Product NDC
68788-8608
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Duloxetine
Labeler
Preferred Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20240320
Source listing expiry
20271231

Source-listed ingredients

  • DULOXETINE HYDROCHLORIDE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-8608-3) · 68788-8608-3
  • 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-8608-6) · 68788-8608-6
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-8608-9) · 68788-8608-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Duloxetine — United States | Molindra Medicines